The FDA has announced it is investigating tampons sold by 14 companies after a July study revealed the presence of harmful chemicals, including lead, cadmium, and arsenic. The study, published in Environmental International, found 16 chemicals in these products, raising alarms about their potential health risks.
Sen. Patty Murray (D-WA) prompted the investigation after sending a letter to the FDA urging action. Murray expressed concern about the safety of tampons, saying, “Women’s health has often been overlooked. It’s time we address these concerns and ensure the safety of the millions of women who use tampons daily.”
Heavy metals like lead and cadmium are linked to serious health conditions, such as cancer, kidney disease, and fertility problems. With 52–86% of women regularly using tampons, the risks could affect millions.
One of the key questions the FDA’s investigation will address is whether these harmful chemicals can be absorbed through the vaginal wall when tampons are used. The original study did not explore this possibility, leaving many questions about the true risks posed by these products.
The FDA is working on a comprehensive response to Murray’s letter and has pledged to provide a thorough review of the findings. Women across the country are now waiting for answers about the safety of tampons and their potential health impacts.
